Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
1841 |
|
| Actual shortage: | 45 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 13 (1%) | |
| Resolved: | 1782 (97%) | |
Discontinuation Reports |
82 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 79 (96%) | |
| Reversed: | 2 (2%) | |
Late reports |
439 (23%) |
|
Overdue reports |
3 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ CANDESARTAN PLUS | 12.5MG 32MG | TABLET | Resolved | 2023-06-05 | 2024-02-21 | 193703 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2019-01-22 | 2020-08-17 | 73158 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2019-01-22 | 2020-09-15 | 73161 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2021-09-08 | 2022-12-12 | 145343 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2021-09-08 | 2023-05-03 | 145346 |
| SANDOZ LOSARTAN HCT | 12.5MG 50MG | TABLET | Resolved | 2023-05-01 | 2023-05-09 | 191382 |
| SANDOZ TELMISARTAN HCT | 12.5MG 80MG | TABLET | Resolved | 2017-06-26 | 2017-09-07 | 13944 |
| SANDOZ TELMISARTAN HCT | 12.5MG 80MG | TABLET | Resolved | 2018-12-13 | 2020-08-26 | 69545 |
| SANDOZ TELMISARTAN HCT | 12.5MG 80MG | TABLET | Resolved | 2019-02-18 | 2020-08-24 | 76221 |
| SANDOZ TELMISARTAN HCT | 12.5MG 80MG | TABLET | Resolved | 2021-07-05 | 2021-07-26 | 141781 |
| SANDOZ TELMISARTAN HCT | 12.5MG 80MG | TABLET | Resolved | 2022-12-28 | 2023-01-19 | 179524 |
| SANDOZ TELMISARTAN HCT | 12.5MG 80MG | TABLET | Resolved | 2023-06-05 | 2023-07-25 | 193737 |
| SANDOZ TELMISARTAN HCT | 12.5MG 80MG | TABLET | Resolved | 2023-07-17 | 2023-08-08 | 198849 |
| SANDOZ TELMISARTAN HCT | 12.5MG 80MG | TABLET | Resolved | 2023-10-10 | 2023-10-17 | 206704 |
| SANDOZ ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2017-07-05 | 2017-10-25 | 14659 |
| SANDOZ ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2019-02-04 | 2019-03-13 | 74593 |
| DOBUTAMINE INJECTION USP | 12.5MG | LIQUID | Resolved | 2022-09-01 | 2022-10-26 | 168466 |
| DOBUTAMINE INJECTION USP | 12.5MG | LIQUID | Resolved | 2023-04-21 | 2023-07-05 | 190144 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2017-03-14 | 2017-07-05 | 2586 |
| SANDOZ DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-02-05 | 2020-04-01 | 38703 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-08-18 | 2021-08-18 | 144303 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |